Pierre Attali Selected Research

1-aminomethylphosphonic acid

7/2017	Gene therapy for patients with advanced solid tumors: a phase I study using gene electrotransfer to muscle with the integrin inhibitor plasmid AMEP.
9/2013	Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre Attali Research Topics

Disease

7	Fibrosis (Cirrhosis) 01/2022 - 09/2013
4	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2017
3	Infections 01/2019 - 09/2013
2	Hepatitis C 01/2022 - 01/2019
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020 - 01/2008
2	Vertigo (Positional Vertigo) 10/2019 - 12/2018
2	Neoplasms (Cancer) 07/2017 - 01/2008
2	Candidiasis (Moniliasis) 07/2010 - 01/2008
1	Brain Diseases (Brain Disorder) 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Hepatopulmonary Syndrome 01/2022
1	Disease Progression 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Ascites 01/2022
1	Portal Hypertension 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Hemorrhage 01/2022
1	Hepatorenal Syndrome 01/2022
1	Hydrothorax 01/2022
1	Hypotension (Low Blood Pressure) 01/2020
1	Deglutition Disorders (Dysphagia) 01/2020
1	Nausea 01/2020
1	Stomatitis 01/2020
1	Esophageal and Gastric Varices (Esophageal Varices) 01/2019
1	Neutropenia 01/2019
1	Asthenia 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Coinfection 01/2019
1	Hypertension (High Blood Pressure) 01/2018
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Diabetes Mellitus 01/2018
1	Viremia 01/2018
1	Edema (Dropsy) 07/2017
1	Chronic Hepatitis B 01/2017
1	Herpes Labialis (Fever Blister) 07/2014
1	Fever (Fevers) 09/2013
1	Melanoma (Melanoma, Malignant) 09/2013
1	Urinary Incontinence 01/2011

Drug/Important Bio-Agent (IBA)

3	TabletsIBA 01/2020 - 01/2008
3	Pharmaceutical PreparationsIBA 01/2019 - 01/2011
3	Antiviral Agents (Antivirals)IBA 01/2019 - 07/2014
2	BilirubinIBA 01/2022 - 01/2018
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2017
2	InterferonsIBA 11/2018 - 01/2017
2	1-aminomethylphosphonic acidIBA 07/2017 - 09/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 09/2013
2	Miconazole (Monistat)FDA LinkGeneric 07/2010 - 01/2008
1	ABO Blood-Group SystemIBA 01/2022
1	AlbuminsIBA 01/2022
1	Blood Group Antigens (Blood Groups)IBA 01/2022
1	Clonidine (ST 155)FDA LinkGeneric 01/2020
1	Histamine Antagonists (Antihistamines)IBA 10/2019
1	Coffee FDA Link 01/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2019
1	seliforantIBA 12/2018
1	Serum AlbuminIBA 01/2018
1	omega-Chloroacetophenone (Mace)IBA 01/2018
1	IntegrinsIBA 07/2017
1	peginterferon alfa-2a (Pegasys)FDA Link 01/2017
1	Fetal Proteins (Fetoprotein)IBA 01/2017
1	AntigensIBA 01/2017
1	Hepatitis B e AntigensIBA 01/2017
1	Alanine Transaminase (SGPT)IBA 01/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 07/2014
1	telaprevirIBA 07/2014
1	Ribavirin (Virazole)FDA LinkGeneric 07/2014
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 07/2014
1	Erythropoietin FDA Link 09/2013
1	Peptides (Polypeptides)IBA 09/2013
1	C-Reactive ProteinIBA 09/2013
1	besipirdineIBA 01/2011
1	Clotrimazole (Lotrimin)FDA LinkGeneric 07/2010
1	Antifungal AgentsIBA 01/2008

Therapy/Procedure

7	Therapeutics 01/2020 - 01/2008
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2017
1	Transplantation 01/2018
1	Aftercare (After-Treatment) 07/2017
1	Radiotherapy 01/2008